학술논문

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
Document Type
Article
Source
NEJM Evidence; Feb2024, Vol. 3 Issue 2, p9-9, 1p
Subject
BODY weight
CONFIDENCE intervals
MYOCARDIAL infarction
DIABETES
CARDIOVASCULAR diseases
RANDOMIZED controlled trials
RISK assessment
COMPARATIVE studies
DAPAGLIFLOZIN
BLIND experiment
DESCRIPTIVE statistics
SODIUM-glucose cotransporter 2 inhibitors
STATISTICAL sampling
ODDS ratio
HEART failure
Language
ISSN
27665526
Abstract
Copyright of NEJM Evidence is the property of MMS Publications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access